Nature Medicine· Marianne Guenot·· 2026-10-16精选AI 评分74
CAR T 治疗自身免疫病遭遇安全审视:最近多项试验被叫停
A reality check for autoimmune CAR T cells
AI 导读
原文指出 CAR T 治疗自身免疫病的预期是重置免疫并达到深度缓解,但近期多起试验被叫停令安全性、患者筛选与可接受风险重受关注。
推荐理由
原文复盘了 CAR T 在自免领域从被寄望到多起试验被叫停的转折,帮读者判断当前争议焦点
正文 · 原文
Nature Medicine, Published online: 16 October 2026; doi:10.1038/d41591-026-00052-0
The hope with CAR T cell therapies for autoimmune disease is that they can reset the immune system and induce deep remission. But recent trial pauses have renewed concerns about safety, patient selection and acceptable risk.
来源:Nature Medicine · nature.com